370P A Phase Ib Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Subjects with Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies: A Subgroup Analysis of Efficacy in PIK3CA/AKT1/PTEN-altered Subjects

P. Zhang, B. Xu,T. Sun, Y. Wang, W. Li, Z. Tong,S. Phadke,T.M. Feinstein, J. Qu, P. Guo, W. Ma, M. Zhang, Y. Yue

Annals of Oncology（2024）

Cited 0|Views2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined